Zerhouni resigns as NIH head

The 15th head of the National Institutes of Health, linkurl:Elias Zerhouni,;http://www.the-scientist.com/blog/display/42733/ will step down from his post, he announced today (Sept 24). In a conference call with reporters today, Zerhouni said that he would be leaving NIH at the end of October as a part of what he called "the natural cycle of tenures for this position." "It's with mixed emotions that I move on," he said. President George W. Bush linkurl:appointed;http://www.the-scientist.com/ar

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The 15th head of the National Institutes of Health, linkurl:Elias Zerhouni,;http://www.the-scientist.com/blog/display/42733/ will step down from his post, he announced today (Sept 24). In a conference call with reporters today, Zerhouni said that he would be leaving NIH at the end of October as a part of what he called "the natural cycle of tenures for this position." "It's with mixed emotions that I move on," he said. President George W. Bush linkurl:appointed;http://www.the-scientist.com/article/display/13166/ Zerhouni in May 2002, on the tail end of a five year NIH budget doubling. These halcyon days at NIH led Zerhouni to craft the linkurl:"NIH Roadmap for Medical Research,";http://www.the-scientist.com/article/display/14454/ a sweeping $2 billion, five-year plan meant to invigorate the biomedical enterprise through focusing NIH resources on bioinformatics, systems and structural biology, genomic database establishment, and nanomedicine projects, encouraging cross-disciplinary collaboration, and funding clinical and translational research. "I think it's clear that science has changed tremendously with the explosion of discoveries," Zerhouni said on the conference call. The Roadmap will likely form the base of Zerhouni's legacy at NIH, but he saw the agency through his fair share of controversy and turmoil as well. On Zerhouni's watch the NIH budget plateaued, and federal funding of the agency remains level today. He also watched the success rates for new R01 grants linkurl:plummet;http://www.the-scientist.com/2008/9/1/30/1/ from about 18% in 2002 to about 9% in 2005. Zerhouni received criticism for his appointment of David Schwartz, former director of the National Institute of Environmental Health Sciences, who linkurl:resigned;http://www.the-scientist.com/blog/display/54296/ from his post earlier this year amid allegations of mismanagement and misconduct. Senator Charles Grassley (R-IA) corresponded frequently with Zerhouni regarding NIH-funded scientists who the Senator alleged improperly disclosed financial ties to industry. Prior to his appointment as head of NIH, the Algerian-born radiologist was the executive vice-dean of Johns Hopkins University School of Medicine and a professor of radiology and biomedical engineering there and at Eastern Virginia Medical School. Zerhouni said today that he doesn't "have a job lined up," and that he plans on resting before transitioning into a new position. "I wanted to take some time out," he said.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution